Northwest Biotherapeutics | NWBO - DÍVIDA





DÍVIDA Alterar Data
Agenus USD 35.54M 2.34M 2025-03
AstraZeneca USD 33.92B 4.3B 2026-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Celldex Therapeutics USD 2.34M 285K 2025-12
Eisai JPY 236.67B 49.14B 2025-09
Merck USD 49.34B 7.97B 2025-12
Northwest Biotherapeutics USD 32.94M 6.93M 2023-09
Pfizer USD 63.73B 231M 2026-03
Plus Therapeutics USD 3.98M 372K 2023-12
Roche Holding CHF 33.03B 1.41B 2025-06